- Bay willow
- black willow
- white willow
For Patients & Caregivers
Bottom Line: Willow bark is useful in relieving muscle and joint pain, but may have side effects similar to aspirin.
Willow bark is commonly used to treat pain and reduce fevers. It contains a compound called salicin that has been shown to have anti-inflammatory effects. Several studies have shown that willow bark extracts are effective in reducing back pain and osteoarthritis.
Although aspirin is developed from salicin, a direct comparison between aspirin benefits and willow bark benefits cannot be made. At the same time, aspirin-like side effects may occur with willow bark.
- To reduce fever
Willow bark is thought to act in a similar way as aspirin, but clinical trials have not been performed.
- To treat pain, including muscle and joint pain
Clinical trials have shown that willow bark extract is effective in treating low back pain. Other study results are mixed for its ability to relieve osteoarthritis pain.
- To aid in weight loss
There are no studies to indicate that willow bark can aid in weight loss, and a case report of allergic reaction in someone who used a weight-loss product with willow bark.
Arthritis of the knee and hip joint
Several small short-term studies lasting 2 weeks (with 78 patients) and 6 weeks (with 88 patients) have found that willow bark may help reduce pain associated with osteoarthritis, but only the 2 week study was a randomized trial. Another randomized trial lasting 6 weeks with the largest number of patients (127 patients) did not show benefit.
Low back pain
In a 4-week study, 210 patients with intense chronic low back pain were split randomly into 3 groups: low- or high-dose willow bark extract, or placebo. Of 191 patients completing the study, 39% of 65 patients in the high-dose group were pain-free during Week 4, and 21% of 67 in the low-dose group were also pain-free. Only 6% of 59 patients in the placebo group were pain-free during the same treatment period. In addition, the high-dose group had benefit after only 1 week of treatment. However, 1 patient in the low-dose group had a severe allergic reaction.
- You are taking warfarin or other blood thinners: Willow bark may increase the risk of bleeding.
- You are taking non-steroidal anti-inflammatory drugs (NSAIDs): Willow bark may increase the risk of stomach and intestinal damage and bleeding.
- You have sensitivity to aspirin or aspirin-containing products.
- You have asthma, breathing problems, chest tightness, or throat tightness.
- You have stomach problems or an ulcer.
- You are having skin rash, hives, or itchy / swollen skin.
- Stomach or intestinal discomfort, allergic reaction, sudden rash, or itching
- May prevent blood clotting or cause bleeding problems
- Serious allergic reaction in a 25-year-old woman with a history of allergy to aspirin products. The product used was a supplement promoted for weight-loss that contained willow bark.
- Acute breathing distress in a 61-year-old woman who suddenly became short of breath and coughed repeatedly after taking willow bark.
For Healthcare Professionals
Willow is a deciduous tree native to Europe, Asia and some parts of North America. Its bark has been used for thousands of years in China and Europe as a remedy for fevers and pain. The bioactive compound in willow bark is salicin.
Willow bark extracts exert anti-inflammatory (1), antiplatelet (2), and antiproliferative (3) effects in vitro.
Clinical studies indicate that they may help manage back pain (5)(6), although studies of osteoarthritis are mixed (7)(8)(9), and possibly negative for rheumatoid arthritis (6)(9).
Topical application of salicin may help reduce skin aging (10).
In vitro and animal models suggest that salicin has antitumor and antiangiogenic effects (4).
Aspirin, a drug derived from salicin, has been studied for the prevention of cardiovascular diseases as well as cancer (21). However, willow bark should not be used as a substitute for aspirin because of the variation in its potency.
Children should not be given willow bark because of the potential for developing Reye syndrome, a serious condition associated with the use of aspirin (22).
Although the anti-inflammatory activity of willow bark extract is mostly attributed to salicin (13), catechol and flavonoid compounds have also been found responsible (12). Willow bark inhibits pro-inflammatory cytokines (tumor necrosis factor [TNF]-alpha), cyclo-oxygenase (COX)-2, and nuclear translocation of the transcription factor NF-κB (1). It was also found to significantly raise low glutathione (GSH) levels, thereby limiting lipid peroxidation (14).
Antiproliferative effects on human colon and lung cancer cells are due to growth-inhibition and apoptotic induction (15). In vitro and animal models suggest salicin can inhibit reactive oxygen species (ROS) and extracellular signal-regulated kinase (ERK) signaling pathways to produce antiangiogenic effects (4).
Gastrointestinal discomfort; allergic reaction, erythema, pruritus (sudden rash, itching) (5)(7)(17).
May inhibit platelet aggregation or cause bleeding complications (2)(16).
Anaphylaxis: In a 25-year-old woman with a history of allergy to acetylsalicylic acid, from the use of a supplement promoted for weight-loss that contained willow bark (18).
Acute respiratory distress syndrome: In a 61-year-old woman with history of hypertension and osteoarthritis after taking a willow bark supplement. Symptoms included sudden dyspnea and non-productive cough, and there was no history of drug or supplement allergy (19).
Beer AM, Wegener T. Willow bark extract (Salicis cortex) for gonarthrosis and coxarthrosis - Results of a cohort study with a control group. Phytomedicine. 2008 Nov;15(11):907-13.
In this open multicenter study, 88 patients aged 50–75 years with hip and knee osteoarthritis (OA) were treated with a standardized willow bark extract, and 40 patients received standard therapy. Most patients (92%) in the willow bark extract group were prescribed 1.572 g (equivalent to salicin 240 mg). Effectiveness of treatments was determined by clinical findings, recording of adverse events, global tolerance and by patient assessment: Western Ontario and McMaster Universities Arthritis Index (WOMAC) questions concerning pain and stiffness, and questions on general state of health. At 6 weeks from study initiation, researchers reported that the willow bark extract was superior to conventional therapy and well tolerated with no adverse effects.
Biegert C, et al. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. J Rheumatol . 2004;31:2121-2130.
This double-blind dual-RCT included the evaluation of standardized willow bark extract in patients with hip or knee OA. A total of 127 patients with WOMAC pain scores ≥30 mm were randomized to receive either willow bark extract (dosage equivalent to salicin 240 mg daily), diclofenac 100 mg daily, or placebo (n=43, 43, 41, respectively). At 6-week follow-up, differences in pain scores for those taking willow bark extract compared with placebo was not statistically significant, while the difference between diclofenac and placebo was highly significant. The investigators also conducted a pilot double-blind RCT to evaluate willow bark for rheumatoid arthritis at the same dosage, which did not show any benefit.
Schmid B, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res. 2001;15:344-350.
Willow bark extract (dosage equivalent to salicin 240 mg daily) was evaluated in this 2-week study to treat osteoarthritis. A total of 78 patients (39 extract, 39 placebo) participated in the trial. Primary outcome measured was WOMAC pain scores. Secondary outcomes included WOMAC stiffness and physical function and visual analogue scale (VAS) pain and physical function scale scores, plus final assessments by both patients and investigators. WOMAC pain score was reduced by 14% from baseline after 2 weeks of active treatment, compared with an increase of 2% in the placebo group, with significant differences between active treatment and placebo for WOMAC pain scores (d=6.5 mm, 95% CI=0.2–12.7 mm, P=.047). VAS and final overall assessments confirmed this result (patients, P=.0002; investigators, P=.0073). Investigators concluded willow bark produced a moderate analgesic effect in osteoarthritis and was well tolerated.
Chrubasik S, et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med. 2000;109:9-14.
In this 4-week study, a total of 210 patients with exacerbated chronic low back pain were randomly assigned to receive oral willow bark extract, either low- or high-dose (120 mg or 240 mg salicin, respectively), or placebo, with tramadol as a sole rescue medication, in a 4-week blinded trial. Primary outcome measure was the proportion of patients who were pain-free without tramadol for ≥5 days during Week 4. Of 191 patients who completed the study, 27 (39%) of 65 in the high-dose group, 15 (21%) of 67 in the low-dose group, and 4 (6%) of 59 in the placebo group were pain-free during Week 4 (P<.001). Response in the high-dose group was demonstrated after only 1 week of treatment. Significantly more patients in the placebo group required tramadol (P<.001) during each week of the study. One patient in the low-dose group suffered a severe allergic reaction, possibly due to the extract.